Skip to content

    Recently Viewed

      Listening...

      Home / Our Company / Our societal impact / Global Health Equity /
      Enhancing the Efforts of Advocacy Organizations

      Enhancing the Efforts of Advocacy Organizations

      We work with partners globally to strengthen advocacy around disease prevention.

      Continuing the fight against HIV, Tuberculosis and Malaria

      This week is “UN Week” which marks the annual United Nations General Assembly meeting in New York. Top leaders from around the world have descended upon NY to discuss many pressing issues on the global agenda, including the SDG goals and improving health worldwide.

      Johnson & Johnson global public health supports World AIDS Day

      With an estimated 37 million people currently living with HIV globally and 2.1 million people becoming newly infected each year, Johnson & Johnson stands united with the global community to fight HIV and care for those infected, and impacted.

      Uniting for an HIV-free world infographic

      Learn how Johnson & Johnson is building on a 25-year legacy of commitment to end HIV through innovative partnerships and investments.

      Challenging innovators to make DREAMS come true

      In this Huffington Post blog, USAID Ambassador Deborah L. Birx, M.D., discusses how the DREAMS partnership aims to help combat HIV in adolescent girls and young women.

      DREAMS partners announce $85 million innovation challenge focused on solutions for reducing HIV infections

      Johnson & Johnson issued a call for innovative ideas to reduce HIV infections in adolescent girls and young women in 10 sub-Saharan African countries as part of the DREAMS Innovation Challenge, supported by PEPFAR.

      A road to hope: mothers2mothers

      mothers2mothers connects mentor mothers with women in communities who are living with HIV to empower them to keep themselves and their babies healthy.

      Save the Children partnership could help millions of children

      Johnson & Johnson announced a global partnership with Save the Children to support its core mission to improve newborn survival.

      Funding zika but but forgetting tuberculosis

      Additional support and funding is needed to help fight TB worldwide. Read more in this Health Affairs blog from Friends of the Global Fight Against AIDS, Tuberculosis and Malaria.

      The battle to end TB

      Learn how Johnson & Johnson employees “Unite to End TB” and bring new hope to those suffering from tuberculosis in Vietnam, South Africa and India.

      Antimicrobial resistance: A growing threat

      World Economic Forum, Davos, Switzerland. Addressing the emergence of superbugs and drug-resistant bacteria is critical to our economic future and global health.

      Call for new collective action to address antimicrobial resistance

      Johnson & Johnson announced it has joined more than 80 companies and organizations in signing the Declaration on Combating Antimicrobial Resistance, an industry-wide call to action that outlines how industry and governments can work together to support sustained innovation to address this growing problem.

      “Big Pharma” accelerates fight against “Superbugs”

      Bloomberg reports on the industry-wide partnership to accelerate the development of drugs and diagnostics to help fight antimicrobial resistance.

      Public-private partnership to combat tuberculosis

      Janssen and USAID entered into a new Memorandum of Understanding, as part of the U.S Government’s National Action Plan for combatting multi-drug resistant tuberculosis (MDR-TB), agreeing to expand patient access to novel MDR-TB therapies and increase funding for program partners.

      The preventable disease we all should be fighting against

      Johnson & Johnson leadership reflects on a trip to South Africa where they met Chandre Heaton, a young woman who overcame XDR-TB.

      Bolstering the world’s defense against antimicrobial resistance

      Janssen leaders urged consideration of a special framework for innovation in antibiotics research and development at a congressional hearing.

      United States General Assembly continues the fight against HIV, TB and Malaria

      Johnson & Johnson Vice President of Innovation, Global Public Health and Science Policy Communication, Seema Kumar shares her key highlights from the Global Fund Replenishment Conference to Fight HIV, Tuberculosis and Malaria.

      Partnering with Global Citizen to improve human health

      Johnson & Johnson partnered with social action platform Global Citizen to elevate the global importance of strong public health programs.

      Davos 2016: Global public health and STEM education

      Learn more about key themes related to global public health and STEM education that emerged at the 2016 World Economic Forum in Davos, Switzerland.

      Our commitment to improving the health of women and children infographic

      Learn about Johnson & Johnson’s commitment to improve the health of women and children in five key areas.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.